Literature DB >> 22170702

Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series.

Marco Piastra1, Daniele De Luca, Maria Pia De Carolis, Alessia Tempera, Eleonora Stival, Francesca Caliandro, Domenico Pietrini, Giorgio Conti, Gabriella De Rosa.   

Abstract

OBJECTIVE: To describe a series of ex-preterm infants admitted to pediatric intensive care unit due to impending hypoxaemic respiratory failure complicated by pulmonary hypertension (PH) who were treated electively combining noninvasive ventilation (NIV) and nebulized iloprost (nebILO).
DESIGN: Open uncontrolled observational study.
SETTING: Pediatric Intensive Care Unit, University Hospital. PATIENTS: Ten formerly preterm infants with impending hypoxaemic respiratory failure and PH, of whom eight had moderate to severe bronchopulmonary dysplasia.
MEASUREMENTS AND MAIN RESULTS: Median age and body weight were 6.0 (2.75-9.50) months and 4.85 (3.32-7.07) kg, respectively. We observed a significant early oxygenation improvement in terms of PaO(2) /FiO(2) increase (P = 0.001) and respiratory rate reduction (P = 0.01). Hemodynamic also improved, as shown by heart rate (P = 0.002) and pulmonary arterial pressure systolic/systolic systemic pressure (PAPs/SSP) ratio reduction (P = 0.0137). NebILO was successfully weaned in positive response cases: 4 infants were discharged on oral sildenafil. Three patients failed noninvasive modality and needed invasive mechanical ventilation; hypoxic-hypercarbic patients were most likely to fail noninvasive approach. Only one patient requiring invasive ventilation died and surviving babies had a satisfactory 1-month post-discharge follow-up. CONCLUSIONS.: The noninvasive approach combining NIV and nebILO for ex-preterm babies with impending respiratory failure and PH resulted to be feasible and quickly achieved significant oxygenation and hemodynamic improvements.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170702     DOI: 10.1002/ppul.21619

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

Review 1.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation.

Authors:  Robert M DiBlasi; Dave N Crotwell; Shuijie Shen; Jiang Zheng; James B Fink; Delphine Yung
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 3.  Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants.

Authors:  N Ambalavanan; J L Aschner
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

4.  Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.

Authors:  Sanne Arjaans; Elvira A H Zwart; Marc Roofthooft; Elisabeth M W Kooi; Arend F Bos; Rolf M F Berger
Journal:  Eur J Pediatr       Date:  2021-02-02       Impact factor: 3.183

Review 5.  Diagnostic Approach to Pulmonary Hypertension in Premature Neonates.

Authors:  Vasantha H S Kumar
Journal:  Children (Basel)       Date:  2017-08-24

Review 6.  Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm.

Authors:  Feriel Fortas; Matteo Di Nardo; Nadya Yousef; Marc Humbert; Daniele De Luca
Journal:  Eur J Pediatr       Date:  2021-06-06       Impact factor: 3.183

Review 7.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Georg Hansmann; Hannes Sallmon; Charles C Roehr; Stella Kourembanas; Eric D Austin; Martin Koestenberger
Journal:  Pediatr Res       Date:  2020-06-10       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.